{"title": "Neu von \u00c4FI: Aktualisierte FAQs zum Masernschutzgesetz", "author": "Resch Media", "url": "https://individuelle-impfentscheidung.de/impfungen/masern.html", "hostname": "individuelle-impfentscheidung.de", "description": "Die Bestimmungen des Masernschutzgesetzes sorgen bei Eltern und Gemeinschaftseinrichtungen f\u00fcr Verwirrung. Der neue Fragenkatalog der \u00c4FI hilft. Jetzt informieren!", "sitename": "individuelle-impfentscheidung.de", "date": "2023-05-30", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Aaby, P., Bukh, J., Leerhoy, J., Lisse, I. M., Mordhorst, C. H. & Pedersen, I. R. (1986). Vaccinated Children Get Milder Measles Infection: A Community Study from Guinea-Bissau. Journal of Infectious Diseases, 154(5), 858\u2013863.\n[doi.org/10.1093/infdis/154.5.858](http://doi.org/10.1093/infdis/154.5.858)\nACA M\u00fcller ADAG Pharma AG. (2009, Oktober). Fachinformation Priorix. dimdi.\n[https://portal.dimdi.de/amispb/doc/pei/Web/2603289-spcde-20091001.pdf](https://portal.dimdi.de/amispb/doc/pei/Web/2603289-spcde-20091001.pdf)\nAckley, S. F., Hacker, J. K., Enanoria, W. T. A., Worden, L., Blumberg, S., Porco, T. C. & Zipprich, J. (2018). Genotype-Specific Measles Transmissibility: A Branching Process Analysis. Clinical Infectious Diseases, 66(8), 1270\u20131275.\n[doi.org/10.1093/cid/cix974](http://doi.org/10.1093/cid/cix974)\nAoki, Y., Mizuta, K., Ikeda, T., Abiko, C., Itagaki, T. & Ahiko, T. (2013). Isolation of Vaccine-Derived Measles Viruses from Children with Acute Respiratory Infection. The Tohoku Journal of Experimental Medicine, 230(2), 111\u2013115.\n[https://doi.org/10.1620/tjem.230.111](https://doi.org/10.1620/tjem.230.111)\nApotheken Umschau. (2018, 6. Februar). Braucht Deutschland eine Impfpflicht? Abgerufen am 9. August 2022, von\n[https://web.archive.org/web/20180711000720/https://www.apotheken-umschau.de/Infektion/Braucht-Deutschland-eine-Impfpflicht-548597.html](https://web.archive.org/web/20180711000720/https://www.apotheken-umschau.de/Infektion/Braucht-Deutschland-eine-Impfpflicht-548597.html)\narznei-telegramm. (2013). DISKUSSION UM DIE MASERNIMPFUNG. arznei-telegramm, 44, 85\u201387. Abgerufen von\n[https://www.arznei-telegramm.de/html/2013_10/1310085_01.html](https://www.arznei-telegramm.de/html/2013_10/1310085_01.html)\nASSET. o. J.\n[Compulsory Vaccination and Rates of Coverage Immunisation in Europe](http://www.asset-scienceinsociety.eu/reports/page1.html). Abruf 14.02.2019\nAugusto, G. F., Cruz, D., Silva, A., Pereira, N., Aguiar, B., Le\u00e7a, A., . . . Freitas, G. (2018). Challenging measles case definition: three measles outbreaks in three Health Regions of Portugal, February to April 2018. Eurosurveillance, 23(28), pii=1800328.\n[doi.org/10.2807/1560-7917.es.2018.23.28.1800328](http://doi.org/10.2807/1560-7917.es.2018.23.28.1800328)\nAvramovich, E., Indenbaum, V., Haber, M., Amitai, Z., Tsifanski, E., Farjun, S., . . . Galor, I. (2018). Measles Outbreak in a Highly Vaccinated Population \u2014 Israel, July\u2013August 2017. MMWR. Morbidity and Mortality Weekly Report, 67(42), 1186\u20131188.\n[doi.org/10.15585/mmwr.mm6742a4](http://doi.org/10.15585/mmwr.mm6742a4)\nBankamp, B., Takeda, M., Zhang, Y., Xu, W. & Rota, P. A. (2011). Genetic Characterization of Measles Vaccine Strains. The Journal of Infectious Diseases, 204(suppl_1), S533\u2013S548.\n[https://doi.org/10.1093/infdis/jir097](https://doi.org/10.1093/infdis/jir097)\nBarkin, R. M. (1975). Measles mortality: a retrospective look at the vaccine era. American Journal of Epidemiology, 102(4), 341\u2013349.\n[doi.org/10.1093/oxfordjournals.aje.a112170](http://doi.org/10.1093/oxfordjournals.aje.a112170)\nBarrett, P., Chaintarli, K., Ryan, F., Cotter, S., Cronin, A., Carlton, L., . . . Migone, C. (2016). An ongoing measles outbreak linked to a suspected imported case, Ireland, April to June 2016. Eurosurveillance, 21(27).\n[https://doi.org/10.2807/1560-7917.es.2016.21.27.30277](https://doi.org/10.2807/1560-7917.es.2016.21.27.30277)\nBeier, D. (2017, Januar). SIKO aktualisiert Impfempfehlungen bei Masern-Mumps-R\u00f6teln, Influenza, Hepatitis B und HPV. Abgerufen am 14. Juli 2022, von\n[www.kvs-sachsen.de/fileadmin/data/kvs/img/Mitglieder/KVS-Mitteilungen/2017-02/2017-02_schutzimpfungen.pdf](http://www.kvs-sachsen.de/fileadmin/data/kvs/img/Mitglieder/KVS-Mitteilungen/2017-02/2017-02_schutzimpfungen.pdf)\nBellini, W. & Rota, P. A. (1998). Genetic Diversity of Wild-Type Measles Viruses: Implications for Global Measles Elimination Programs. Emerging Infectious Diseases, 4(1), 29\u201335.\n[doi.org/10.3201/eid0401.980105](http://doi.org/10.3201/eid0401.980105)\nBennett, J. V., Cutts, F. T. & Katz, S. L. (1999). Edmonston-Zagreb Measles Vaccine: A Good Vaccine With an Image Problem. Pediatrics, 104(5), 1123.\n[https://doi.org/10.1542/peds.104.5.1123](https://doi.org/10.1542/peds.104.5.1123)\nBernsen, R. M. D., & van der Wouden, J. C. (2008). Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children. Pediatric Allergy and Immunology, 19(6), 544\u2013551.\n[https://doi.org/10.1111/j.1399-3038.2007.00684.x](https://doi.org/10.1111/j.1399-3038.2007.00684.x)\nBetsch, C. & B\u00f6hm, R. (2016). Detrimental effects of introducing partial compulsory vaccination: experimental evidence. The European Journal of\n[Public Health](/glossar.html#c138), 26(3), 378\u2013381. [doi.org/10.1093/eurpub/ckv154](https://doi.org/10.1093/eurpub/ckv154)\nBGH. 1977. BGHSt 6, 90; OLG Frankfurt NJW 1977, 2128.\nBianchi, F. P., Stefanizzi, P., de Nitto, S., Larocca, A. M. V., Germinario, C. & Tafuri, S. (2019). Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective\n[Cohort Study](/glossar.html#c62). The Journal of Infectious Diseases, 221(5), 721\u2013728. [doi.org/10.1093/infdis/jiz508](http://doi.org/10.1093/infdis/jiz508)\nBitnun, A., Shannon, P., Durward, A., Rota, P. A., Bellini, W. J., Graham, C., . . . Tellier, R. (1999). Measles Inclusion\u2010Body Encephalitis Caused by the Vaccine Strain of Measles Virus. Clinical Infectious Diseases, 29(4), 855\u2013861.\n[https://doi.org/10.1086/520449](https://doi.org/10.1086/520449)\nBitzegeio, J., Majowicz, S., Matysiak-Klose, D., Sagebiel, D. & Werber, D. (2019). Estimating age-specific vaccine effectiveness using data from a large measles outbreak in Berlin, Germany, 2014/15: evidence for waning immunity. Eurosurveillance, 24(17), pii=1800529.\n[doi.org/10.2807/1560-7917.es.2019.24.17.1800529](http://doi.org/10.2807/1560-7917.es.2019.24.17.1800529)\nBolotin, S., Osman, S., Hughes, S. L., Ariyarajah, A., Tricco, A. C., Khan, S., Li, L., Johnson, C., Friedman, L., Gul, N., Jardine, R., Faulkner, M., Hahn\u00e9, S. J. M., Heffernan, J. M., Dabbagh, A., Rota, P. A., Severini, A., Jit, M., Durrheim, D. N., \u2026 Crowcroft, N. S. (2022). In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A\n[Systematic Review](/glossar.html#c233) and Meta-Analysis. The Journal of Infectious Diseases, 226(7), 1127\u20131139. [https://doi.org/10.1093/infdis/jiac039](https://doi.org/10.1093/infdis/jiac039)\nCampbell, H., Andrews, N., Brown, K. E. & Miller, E. (2007). Review of the effect of measles vaccination on the epidemiology of SSPE. International Journal of Epidemiology, 36(6), 1334\u20131348.\n[https://doi.org/10.1093/ije/dym207](https://doi.org/10.1093/ije/dym207)\nCarazo Perez, S., De Serres, G., Bureau, A. & Skowronski, D. M. (2017). Reduced Antibody Response to Infant Measles Vaccination: Effects Based on Type and Timing of the First Vaccine Dose Persist After the Second Dose. Clinical Infectious Diseases, 65(7), 1094\u20131102.\n[doi.org/10.1093/cid/cix510](http://doi.org/10.1093/cid/cix510)\nCarson, M. M., Spady, D. W., Albrecht, P., Beeler, J. A., Thipphawong, J., Barreto, L., Grimsrud, K. M., & Pabst, H. F. (1995). Measles vaccination of infants in a well-vaccinated population. The Pediatric infectious disease journal, 14(1), 17\u201322.\n[doi.org/10.1097/00006454-199501000-00003](http://doi.org/10.1097/00006454-199501000-00003)\nCDC. (2019). Vaccine Recommendations and Guidelines of the ACIP - Contraindications and Precautions. Abgerufen von\n[https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html](https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html)\nChen, C. J., Lee, P. I., Hsieh, Y. C., Chen, P. Y., Ho, Y. H., Chang, C. J., . . . Lin, T. Y. (2012). Waning population immunity to measles in Taiwan. Vaccine, 30(47), 6721\u20136727.\n[doi.org/10.1016/j.vaccine.2012.05.019](http://doi.org/10.1016/j.vaccine.2012.05.019)\nChen, C. J., Lin, T. Y. & Huang, Y. C. (2018). Letter to the editor: Occurrence of modified measles during outbreak in Taiwan in 2018. Eurosurveillance, 23(37).\n[doi.org/10.2807/1560-7917.es.2018.23.37.1800485](http://doi.org/10.2807/1560-7917.es.2018.23.37.1800485)\nCherry, J. D. (1973). Newer respiratory viruses: their role in respiratory illness of children. Advances in pediatrics, 20, 225\u2013290. Abgerufen von\n[pubmed.ncbi.nlm.nih.gov/4359359/](http://pubmed.ncbi.nlm.nih.gov/4359359/)\nCherry, J. D. & Zahn, M. (2018). Clinical Characteristics of Measles in Previously Vaccinated and Unvaccinated Patients in California. Clinical Infectious Diseases, 67(9), 1315\u20131319.\n[doi.org/10.1093/cid/ciy286](http://doi.org/10.1093/cid/ciy286)\nChristenson, B. & B\u00f6ttiger, M. (1994). Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and\n[booster](/glossar.html#c107) effects on the measles virus. Vaccine, 12(2), 129\u2013133. [doi.org/10.1016/0264-410x(94)90049-3](http://doi.org/10.1016/0264-410x(94)90049-3)\nClemmons, N. S., Gastanaduy, P. A., Fiebelkorn, A. P., Redd, S. B., Wallace, G. S., & Centers for Disease Control and Prevention (CDC) (2015). Measles - United States, January 4-April 2, 2015. MMWR. Morbidity and mortality weekly report, 64(14), 373\u2013376.\nCNSCBT. (2017a, Mai 19). Document elaborat de Centrul Na\u021bional de Supraveghere \u0219i Control al Bolilor Transmisibile. Abgerufen am 21. Mai 2017, von\n[http://www.cnscbt.ro/index.php/informari-saptamanale/rujeola-1/682-situatia-deceselor-datorate-rujeolei-romania-2016-2017/file](http://www.cnscbt.ro/index.php/informari-saptamanale/rujeola-1/682-situatia-deceselor-datorate-rujeolei-romania-2016-2017/file)\nCNSCBT. (2017b, Mai 19). Situatia rujeolei in Romania la data de 19 05 2017. Abgerufen am 21. Mai 2017, von\n[http://www.cnscbt.ro/index.php/informari-saptamanale/rujeola-1/690-situatia-rujeolei-in-romania-la-data-de-19-05-2017-1](http://www.cnscbt.ro/index.php/informari-saptamanale/rujeola-1/690-situatia-rujeolei-in-romania-la-data-de-19-05-2017-1)\nCohen, B., Doblas, D. & Andrews, N. (2008). Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination. Vaccine, 26(50), 6392\u20136397.\n[https://doi.org/10.1016/j.vaccine.2008.08.074](https://doi.org/10.1016/j.vaccine.2008.08.074)\nDe Serres, G., Sciberras, J., Naus, M., Boulianne, N., Duval, B. & Rochette, L. (1999). Protection after Two Doses of Measles Vaccine Is Independent of Interval between Doses. The Journal of Infectious Diseases, 180(1), 187\u2013190.\n[doi.org/10.1086/314847](http://doi.org/10.1086/314847)\nDe Serres, G., Boulianne, N., Defay, F., Brousseau, N., Beno\u00eet, M., Lacoursi\u00e8re, S., . . . Skowronski, D. M. (2012). Higher Risk of Measles When the First Dose of a 2-Dose Schedule of Measles Vaccine Is Given at 12\u201314 Months Versus 15 Months of Age. Clinical Infectious Diseases, 55(3), 394\u2013402.\n[https://doi.org/10.1093/cid/cis439](https://doi.org/10.1093/cid/cis439)\nDean, R. (2014). Stigmatization and Denormalization as Public Health Policies: Some Kantian Thoughts. Bioethics, 28(8), 414\u2013419.\n[doi.org/10.1111/bioe.12019](https://doi.org/10.1111/bioe.12019)\nDefay, F., de Serres, G., Skowronski, D. M., Boulianne, N., Ouakki, M., Landry, M., . . . Ward, B. J. (2013). Measles in Children Vaccinated With 2 Doses of MMR. Pediatrics, 132(5), e1126\u2013e1133.\n[https://doi.org/10.1542/peds.2012-3975](https://doi.org/10.1542/peds.2012-3975)\nDemicheli, V., Rivetti, A., Debalini, M. G. & di Pietrantonj, C. (2012). Vaccines for measles, mumps and rubella in children.\n[Cochrane](/glossar.html#c64) Database of Systematic Reviews, 2012(2), CD004407. [https://doi.org/10.1002/14651858.cd004407.pub3](https://doi.org/10.1002/14651858.cd004407.pub3)\nDeutscher Ethikrat. (2019, 27. Juli). Stellungnahme: Impfen als Pflicht? Abgerufen am 14. Juli 2022, von\n[https://www.ethikrat.org/fileadmin/Publikationen/Stellungnahmen/deutsch/stellungnahme-impfen-als-pflicht.pdf](https://www.ethikrat.org/fileadmin/Publikationen/Stellungnahmen/deutsch/stellungnahme-impfen-als-pflicht.pdf)\nDeutschlandfunk (DLF). (2018a, Februar 24). Thomas Fischbach vs. Jan Leidel - Braucht Deutschland eine Impfpflicht f\u00fcr Kinderkrankheiten? Abgerufen am 9. August 2022, von\n[www.deutschlandfunk.de/thomas-fischbach-vs-jan-leidel-braucht-deutschland-eine-100.html?dram:article_id=411412](https://www.deutschlandfunk.de/thomas-fischbach-vs-jan-leidel-braucht-deutschland-eine-100.html?dram:article_id=411412)\nDeutschlandfunk (DLF). (2018b, November 30). Debatte ums Impfen - \u201eF\u00fcr ein fortschrittliches Land haben wir zu viele Masern-F\u00e4lle\u201c. Abgerufen am 9. August 2022, von\n[www.deutschlandfunk.de/debatte-ums-impfen-fuer-ein-fortschrittliches-land-haben-100.html](https://www.deutschlandfunk.de/debatte-ums-impfen-fuer-ein-fortschrittliches-land-haben-100.html)\nDi Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2021). Vaccines for measles, mumps, rubella, and varicella in children. The Cochrane Database of Systematic Reviews, 11(11), CD004407.\n[https://doi.org/10.1002/14651858.CD004407.pub5](https://doi.org/10.1002/14651858.CD004407.pub5)\nDo, V. A., Biering-S\u00f8rensen, S., Fisker, A. B., Bal\u00e9, C., Rasmussen, S. M., Christensen, L. D., Jensen, K. J., Martins, C., Aaby, P., & Benn, C. S. (2017). Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau. The Journal of infectious diseases, 215(8), 1188\u20131196.\n[https://doi.org/10.1093/infdis/jiw512](https://doi.org/10.1093/infdis/jiw512)\nEuropean Centre for Disease Prevention and Control. (2019). Surveillance Atlas of Infectious Diseases.\n[https://atlas.ecdc.europa.eu/public/index.aspx](https://atlas.ecdc.europa.eu/public/index.aspx)\nEuropean Centre for Disease Prevention and Control. (2023, April 24). Measles\u2014Annual Epidemiological Report for 2022.\n[https://www.ecdc.europa.eu/en/publications-data/measles-annual-epidemiological-report-2022](https://www.ecdc.europa.eu/en/publications-data/measles-annual-epidemiological-report-2022)\nEckerle, I., Keller-Stanislawski, B., Santibanez, S., Buderus, S., Hillmann, M., Drosten, C. & Eis-H\u00fcbinger, A. M. (2013). Nonfebrile Seizures after Mumps, Measles, Rubella, and Varicella-Zoster Virus Combination Vaccination with Detection of Measles Virus RNA in Serum, Throat, and Urine. Clinical and Vaccine Immunology, 20(7), 1094\u20131096.\n[https://doi.org/10.1128/cvi.00084-13](https://doi.org/10.1128/cvi.00084-13)\nEdmonson, M. B. (1990). Mild Measles and Secondary Vaccine Failure During a Sustained Outbreak in a Highly Vaccinated Population. JAMA: The Journal of the American Medical Association, 263(18), 2467.\n[doi.org/10.1001/jama.1990.03440180073035](http://doi.org/10.1001/jama.1990.03440180073035)\nEdmunds, W. J. & Van Hoek, A. J. (2009). The impact of increasing vaccine coverage on the distribution of disease: measles in the UK. Centre for Infections. Abgerufen am 14. Juli 2022 von\n[https://web.archive.org/web/20120503041132/http://www.nice.org.uk/nicemedia/live/12247/45529/45529.pdf](https://web.archive.org/web/20120503041132/http://www.nice.org.uk/nicemedia/live/12247/45529/45529.pdf)\nEkbom, A., Daszak, P., Kraaz, W. & Wakefield, A. J. (1996). Crohn\u2019s disease after in-utero measles virus exposure. The Lancet, 348(9026), 515\u2013517.\n[https://doi.org/10.1016/s0140-6736(96)04429-7](https://doi.org/10.1016/s0140-6736(96)04429-7)\nEMA. (2012). Priorix \u2013 Anhang 3: Zusammenfassung der Merkmale des Arzneimittels, Etikettierung und Packungsbeilage. Abgerufen von\n[https://www.ema.europa.eu/en/documents/referral/priorix-article-30-referral-annex-iii_de.pdf](https://www.ema.europa.eu/en/documents/referral/priorix-article-30-referral-annex-iii_de.pdf)\nEngelhardt, S. J., Halsey, N. A., Eddins, D. L., & Hinman, A. R. (1980). Measles mortality in the United States 1971-1975. American journal of public health, 70(11), 1166\u20131169.\n[doi.org/10.2105/ajph.70.11.1166](http://doi.org/10.2105/ajph.70.11.1166)\nFaden, R. R. (1986). The History and Theory of Informed Consent. New York & Oxford, USA: Oxford University Press.\nFarrington, P., Rush, M., Miller, E., Pugh, S., Colville, A., Flower, A., . . . Morgan-Capner, P. (1995). A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. The Lancet, 345(8949), 567\u2013569.\n[https://doi.org/10.1016/s0140-6736(95)90471-9](https://doi.org/10.1016/s0140-6736(95)90471-9)\nFatemi Nasab, G. S., Salimi, V., Abbasi, S., Adjami Nezhad Fard, F. & Mokhtari Azad, T. (2016). Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran. Pathogens and Disease, 74(8), ftw089.\n[doi.org/10.1093/femspd/ftw089](http://doi.org/10.1093/femspd/ftw089)\nFenger, H. (2009). \u00c4rztliche Gesundheitszeugnisse: Vorsicht ist geboten. Dtsch Arztebl 2009; 106(30): A-1506 / B-1287 / C-1255. Abgerufen von:\n[https://www.aerzteblatt.de/archiv/65460/Aerztliche-Gesundheitszeugnisse-Vorsicht-ist-geboten](https://www.aerzteblatt.de/archiv/65460/Aerztliche-Gesundheitszeugnisse-Vorsicht-ist-geboten)\nFiebelkorn, A. P., Coleman, L. A., Belongia, E. A., Freeman, S. K., York, D., Bi, D., . . . Beeler, J. (2016). Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults. Journal of Infectious Diseases, 213(7), 1115\u20131123.\n[doi.org/10.1093/infdis/jiv555](http://doi.org/10.1093/infdis/jiv555)\nGasta\u00f1aduy, P. A., Funk, S., Lopman, B. A., Rota, P. A., Gambhir, M., Grenfell, B., & Paul, P. (2020). Factors Associated With Measles Transmission in the United States During the Postelimination Era. JAMA pediatrics, 174(1), 56\u201362.\n[https://doi.org/10.1001/jamapediatrics.2019.4357](https://doi.org/10.1001/jamapediatrics.2019.4357)\nGeier, M. R. & Geier, D. A. (2003). Pediatric MMR Vaccination Safety. International Pediatrics, 18(2). Abgerufen von\n[https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.584.5748&rep=rep1&type=pdf](https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.584.5748&rep=rep1&type=pdf)\nGrammens, T., Schirvel, C., Leenen, S., Shodu, N., Hutse, V., Mendes Da Costa, E. & Sabbe, M. (2017). Ongoing measles outbreak in Wallonia, Belgium, December 2016 to March 2017: characteristics and challenges.Eurosurveillance, 22(17), pii=30524.\n[https://doi.org/10.2807/1560-7917.es.2017.22.17.30524](https://doi.org/10.2807/1560-7917.es.2017.22.17.30524)\nGreenwood, K. P., Hafiz, R., Ware, R. S. & Lambert, S. B. (2016). A systematic review of human-to-human transmission of measles vaccine virus. Vaccine, 34(23), 2531\u20132536.\n[ https://doi.org/10.1016/j.vaccine.2016.03.092](http://http://)\nGrgi\u010d-Vitek, M., Frelih, T., Ucakar, V., Fafangel, M., Jordan Markocic, O., Prosenc, K. & Kraigher, A. (2015). An outbreak of measles associated with an international dog show in Slovenia, November 2014. Eurosurveillance,20(3), pii=21012.\n[https://doi.org/10.2807/1560-7917.es2015.20.3.21012](https://doi.org/10.2807/1560-7917.es2015.20.3.21012)\nGlaxoSmithKline GmbH & Co. KG. (2003). Fachinformation Priorix\u00ae, Stand 2003. Abgerufen von:\n[https://www.impfkritik.de/upload/pdf/fachinfo/Priorix-Glaxo-2003-01.pdf](https://www.impfkritik.de/upload/pdf/fachinfo/Priorix-Glaxo-2003-01.pdf)\nGlaxoSmithKline GmbH & Co. KG. (Dezember, 2019). Fachinformation Priorix-Tetra \u00ae. Abgerufen von:\n[https://www.forum-impfen.de/images/Fachinfo/Priorix_Tetra_12_19.pdf](https://www.forum-impfen.de/images/Fachinfo/Priorix_Tetra_12_19.pdf)\nGreenwood, K. P., Hafiz, R., Ware, R. S., & Lambert, S. B. (2016). A systematic review of human-to-human transmission of measles vaccine virus. Vaccine, 34(23), 2531\u20132536.\n[https://doi.org/10.1016/j.vaccine.2016.03.092](https://doi.org/10.1016/j.vaccine.2016.03.092)\nHaire, B., Komesaroff, P., Leontini, R., & Raina MacIntyre, C. (2018). Raising Rates of Childhood Vaccination: The Trade-off Between Coercion and Trust. Journal of bioethical inquiry, 15(2), 199\u2013209.\n[https://doi.org/10.1007/s11673-018-9841-1](https://doi.org/10.1007/s11673-018-9841-1)\nHalsey, N. A. (1993). Increased mortality after high titer measles vaccines. The Pediatric Infectious Disease Journal, 12(6), 462\u2013465.\n[https://doi.org/10.1097/00006454-199306000-00002](https://doi.org/10.1097/00006454-199306000-00002)\nHaralambieva, I. H., Ovsyannikova, I. G., Pankratz, V. S., Kennedy, R. B., Jacobson, R. M. & Poland, G. A. (2013). The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches. Expert Review of Vaccines, 12(1), 57\u201370.\n[https://doi.org/10.1586/erv.12.134](https://doi.org/10.1586/erv.12.134)\nHelfand, R. F., Kim, D. K., Gary, H. E., Edwards, G. L., Bisson, G. P., Papania, M. J., . . . Anderson, L. J. (1998). Nonclassic measles infections in an immune population exposed to measles during a college bus trip. Journal of Medical Virology, 56(4), 337\u2013341. Abgerufen von\n[pubmed.ncbi.nlm.nih.gov/9829639/](http://pubmed.ncbi.nlm.nih.gov/9829639/)\nHussey, G. D., Goddard, E. A., Hughes, J., Ryon, J. J., Kerran, M., Carelse, E., . . . Griffin, D. E. (1996). The Effect of Edmonston-Zagreb and Schwarz Measles Vaccines on Immune Responses in Infants. Journal of Infectious Diseases, 173(6), 1320\u20131326.\n[https://doi.org/10.1093/infdis/173.6.1320](https://doi.org/10.1093/infdis/173.6.1320)\nIchikawa, T., Tsuji, A., Fujino, M., Kusano, R., Sugiyama, R., Oomori, S., . . . Nakayama, T. (2013). Effect of early measles vaccination (AIK-C strain) for preterm infants. Pediatrics International, 55(2), 163\u2013168.\n[https://doi.org/10.1111/ped.12064](https://doi.org/10.1111/ped.12064)\nJavelle, E., Colson, P., Parola, P. & Raoult, D. (2019). Measles, the need for a paradigm shift. European Journal of Epidemiology, 34(10), 897\u2013915.\n[doi.org/10.1007/s10654-019-00569-4](http://doi.org/10.1007/s10654-019-00569-4)\nJefferson, T., Price, D., Demicheli, V. & Bianco, E. (2003). Unintended events following immunization with MMR: a systematic review. Vaccine, 21(25\u201326), 3954\u20133960.\n[https://doi.org/10.1016/s0264-410x(03)00271-8](https://doi.org/10.1016/s0264-410x(03)00271-8)\nKoskiniemi, M., & Vaheri, A. (1989). Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet (London, England), 1(8628), 31\u201334.\n[ https://doi.org/10.1016/s0140-6736(89)91683-8](http://http://)\nKoskiniemi, M., Korppi, M., Mustonen, K., Rantala, H., Muttilainen, M., Herrg\u00e5rd, E., Ukkonen, P., & Vaheri, A. (1997). Epidemiology of encephalitis in children. A prospective multicentre study. European journal of pediatrics, 156(7), 541\u2013545.\n[https://doi.org/10.1007/s004310050658](https://doi.org/10.1007/s004310050658)\nKutter, S. (2015, 24. Februar). Masern-Epidemie: \u201eEine Masern-Impfpflicht wird nichts bringen\u201c. Abgerufen am 9. August 2022, von\n[www.wiwo.de/technologie/forschung/masern-epidemie-eine-masern-impfpflicht-wird-nichts-bringen/11418274.html](https://www.wiwo.de/technologie/forschung/masern-epidemie-eine-masern-impfpflicht-wird-nichts-bringen/11418274.html)\nKweder, H., Ainouze, M., Cosby, S. L., Muller, C. P., L\u00e9vy, C., Verhoeyen, E., . . . Buckland, R. (2014). Mutations in the H, F, or M Proteins Can Facilitate Resistance of Measles Virus to Neutralizing Human Anti-MV Sera. Advances in Virology, 2014, 1\u201318.\n[https://doi.org/10.1155/2014/205617](https://doi.org/10.1155/2014/205617)\nLeuridan, E., Hens, N., Hutse, V., Ieven, M., Aerts, M. & van Damme, P. (2010). Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ, 340(may18 2), c1626.\n[https://doi.org/10.1136/bmj.c1626](https://doi.org/10.1136/bmj.c1626)\nLow, N., Bavdekar, A., Jeyaseelan, L., Hirve, S., Ramanathan, K., Andrews, N. J., . . . Henao Restrepo, A. M. (2015). A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles. New England Journal of Medicine, 372(16), 1519\u20131529.\n[https://doi.org/10.1056/nejmoa1407417](https://doi.org/10.1056/nejmoa1407417)\nL\u00f6ll, C. (2012, 8. November). Neuerkrankungen: Masern auf dem Weg zur Erwachsenen-Krankheit. DIE WELT. Abgerufen von\n[https://www.welt.de/gesundheit/article13679613/Masern-auf-dem-Weg-zur-Erwachsenen-Krankheit.html](https://www.welt.de/gesundheit/article13679613/Masern-auf-dem-Weg-zur-Erwachsenen-Krankheit.html)\nMagdzik, W. & Zieli\u0144ski, A. (2002). SZCZEPIENIA PRZECIW \u015aWINCE - ICH SKUTECZNO\u015a\u0106 I NIEPO\u017b\u0104DANE ODCZYNY POSZCZEPIENNE. Przegl\u0105d Epidemiologiczny, 56, 377\u2013389.\nMancuso, J. D., Krauss, M. R., Audet, S. & Beeler, J. A. (2008). ELISA underestimates measles antibody seroprevalence in US military recruits. Vaccine, 26(38), 4877\u20134878.\n[https://doi.org/10.1016/j.vaccine.2008.06.028](https://doi.org/10.1016/j.vaccine.2008.06.028)\nMarinova, L., Muscat, M., Mihneva, Z. & Kojouharova, M. (2009). An update on an ongoing measles outbreak in Bulgaria, April-November 2009. Eurosurveillance, 14(50), 19442.\n[https://doi.org/10.2807/ese.14.50.19442-en](https://doi.org/10.2807/ese.14.50.19442-en)\nMartins, C., Garly, M. L., Bale, C., Rodrigues, A., Benn, C. S., Whittle, H. & Aaby, P. (2013). Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: A serological study within a randomised trial of different measles vaccines. Vaccine, 31(48), 5766\u20135771.\n[https://doi.org/10.1016/j.vaccine.2013.08.044](https://doi.org/10.1016/j.vaccine.2013.08.044)\nMartins, C. L., Benn, C. S., Andersen, A., Bal\u00e9, C., Schaltz-Buchholzer, F., Do, V. A., . . . Garly, M. L. (2014). A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital Admissions. The Journal of Infectious Diseases, 209(11), 1731\u20131738.\n[https://doi.org/10.1093/infdis/jit804](https://doi.org/10.1093/infdis/jit804)\nMathias, R. G., Meekison, W. G., Arcand, T. A. & Schechter, M. T. (1989). The role of secondary vaccine failures in measles outbreaks. American Journal of Public Health, 79(4), 475\u2013478.\n[doi.org/10.2105/ajph.79.4.475](http://doi.org/10.2105/ajph.79.4.475)\nMatysiak-Klose, D. (2013). Hot Spot: Epidemiologie der Masern und R\u00f6teln in Deutschland und Europa. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 56(9), 1231\u20131237.\n[https://doi.org/10.1007/s00103-013-1799-x](https://doi.org/10.1007/s00103-013-1799-x)\nMcLean, H. Q., Fiebelkorn, A. P., Temte, J. L., Wallace, G. S., & Centers for Disease Control and Prevention (2013). Prevention of measles, rubella, congenital rubella\n[syndrome](/glossar.html#c153), and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 62(RR-04), 1\u201334.\nMDR. (2020).\n[EXAKT vom 18.03.2020](https://www.ardmediathek.de/mdr/player/Y3JpZDovL21kci5kZS9iZWl0cmFnL2Ntcy85ZGQyMGEzYy04YTBiLTQ0YmItOTk4My0zOTA2YmYyMmE0YTQ/masern-impfpflicht-wird-umgangen). Abruf 19.03.2020\nMerck Sharp & Dohme B.V, M.-M.-R. (2020, August). Fachinformation M-M-RVAXPRO. forum-impfen.de.\n[https://www.forum-impfen.de/images/Fachinfo/M_M_RVAXPRO_08_20.pdf](https://www.forum-impfen.de/images/Fachinfo/M_M_RVAXPRO_08_20.pdf)\nMerck Sharp & Dohme B.V. (2022, Juli 22). Fachinformation ProQuad. fachinfo.de.\n[https://www.fachinfo.de/pdf/021469](https://www.fachinfo.de/pdf/021469)\nMette, A., Reuss, A. M., Feig, M., Kappelmayer, L., Siedler, A., Eckmanns, T. & Poggensee, G. (2011). Under-Reporting of Measles. Deutsches \u00c4rzteblatt international, 108(12), 191\u2013196.\n[https://doi.org/10.3238/arztebl.2011.0191](https://doi.org/10.3238/arztebl.2011.0191)\nMHRA. (2003, 22. Mai). Statement from the Medicine and Healthcare Regulatory Agency (MHRA). Abgerufen am 14. Juli 2022, von\n[https://webarchive.nationalarchives.gov.uk/ukgwa/20141205150130/http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019510.pdf](https://webarchive.nationalarchives.gov.uk/ukgwa/20141205150130/http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019510.pdf)\nMiller, C., Andrews, N., Rush, M., Munro, H., Jin, L. & Miller, E. (2004). The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990\u20132002. Archives of Disease in Childhood, 89(12), 1145\u20131148.\n[https://doi.org/10.1136/adc.2003.038489](https://doi.org/10.1136/adc.2003.038489)\nMiller E. (2015). Controversies and challenges of vaccination: an interview with Elizabeth Miller. BMC medicine, 13, 267.\n[https://doi.org/10.1186/s12916-015-0508-z](https://doi.org/10.1186/s12916-015-0508-z)\nMillson, D. (1989). BROTHER-TO-SISTER TRANSMISSION OF MEASLES AFTER MEASLES, MUMPS, AND RUBELLA IMMUNISATION. The Lancet, 333(8632), 271.\n[https://doi.org/10.1016/s0140-6736(89)91274-9](https://doi.org/10.1016/s0140-6736(89)91274-9)\nMizumoto, K., Kobayashi, T. & Chowell, G. (2018). Transmission potential of modified measles during an outbreak, Japan, March\u2012May 2018. Eurosurveillance, 23(24).\n[doi.org/10.2807/1560-7917.es.2018.23.24.1800239](http://doi.org/10.2807/1560-7917.es.2018.23.24.1800239)\nMonafo, W., Haslam, D., Roberts, R., Zaki, S., Bellini, W. & Coffin, C. (1994). Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. The Journal of Pediatrics, 124(2), 273\u2013276.\n[https://doi.org/10.1016/s0022-3476(94)70318-3](https://doi.org/10.1016/s0022-3476(94)70318-3)\nMorfin, F., Beguin, A., Lina, B. & Thouvenot, D. (2002). Detection of measles vaccine in the throat of a vaccinated child. Vaccine, 20(11\u201312), 1541\u20131543.\n[https://doi.org/10.1016/s0264-410x(01)00495-9](https://doi.org/10.1016/s0264-410x(01)00495-9)\nMoss, W. J., Griffin, D. E., & Feinstone, W. H. (2009). Measles. Vaccines for Biodefense and Emerging and Neglected Diseases, 551\u2013565.\n[https://doi.org/10.1016/B978-0-12-369408-9.00030-5](https://doi.org/10.1016/B978-0-12-369408-9.00030-5)\nMossong, J. & Muller, C. P. (2003). Modelling measles re-emergence as a result of waning of immunity in vaccinated populations. Vaccine, 21(31), 4597\u20134603.\n[doi.org/10.1016/s0264-410x(03)00449-3](http://doi.org/10.1016/s0264-410x(03)00449-3)\nMossong, J., Nokes, D. J., Edmunds, W. J., Cox, M. J., Ratnam, S. & Muller, C. P. (1999). Modeling the Impact of Subclinical Measles Transmission in Vaccinated Populations with Waning Immunity. American Journal of Epidemiology, 150(11), 1238\u20131249.\n[doi.org/10.1093/oxfordjournals.aje.a009951](http://doi.org/10.1093/oxfordjournals.aje.a009951)\nMuller, C. P. (2001). Measles elimination: old and new challenges? Vaccine, 19(17\u201319), 2258\u20132261.\n[https://doi.org/10.1016/s0264-410x(00)00455-2](https://doi.org/10.1016/s0264-410x(00)00455-2)\nMurti, M., Krajden, M., Petric, M., Hiebert, J., Hemming, F., Hefford, B., . . . van Buynder, P. (2013). Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013. Eurosurveillance, 18(49), pii=20649.\n[https://doi.org/10.2807/1560-7917.es2013.18.49.20649](https://doi.org/10.2807/1560-7917.es2013.18.49.20649)\nNAVKO (2014). Bericht der Nationalen Verifizierungskommission Masern/R\u00f6teln zum Stand der Eliminierung der Masern und R\u00f6teln in Deutschland 2013. Robert Koch-Institut. Abgerufen am 14. Juli 2022, von\n[https://web.archive.org/web/20190122224140/http://www.rki.de/DE/Content/Kommissionen/NAVKO/Berichte/Bericht_2013_de.pdf?__blob=publicationFile](https://web.archive.org/web/20190122224140/http://www.rki.de/DE/Content/Kommissionen/NAVKO/Berichte/Bericht_2013_de.pdf?__blob=publicationFile)\nNeufeind, J., Schmid-K\u00fcpke, N., Rehfuess, E., Betsch, C., & Wichmann, O. (2022). How a generally well-accepted measles vaccine mandate may lead to inequities and decreased vaccine uptake: A preregistered survey study in Germany. BMC Public Health, 22(1), 1846.\n[https://doi.org/10.1186/s12889-022-14075-y](https://doi.org/10.1186/s12889-022-14075-y)\nOlesen, A. B., Juul, S., & Thestrup-Pedersen, K. (2003). Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection. Acta Dermato-Venereologica, 83(6), 445\u2013450.\n[https://doi.org/10.1080/00015550310014997](https://doi.org/10.1080/00015550310014997)\nOrenstein, W., Offit, P., Edwards, K. M. & Plotkin, S. (2017). Plotkin\u2019s Vaccines (7. Aufl.). Philadelphia, U.S.A.: Elsevier.\n[https://doi.org/10.1016/C2013-0-18914-3](https://doi.org/10.1016/C2013-0-18914-3)\nPanum, P. L. (1939). Observations Made During the Epidemic of Measles on the Faroe Islands in the Year 1846. Journal of the American Medical Association, 115(20), 1747.\n[doi.org/10.1001/jama.1940.02810460079037](http://doi.org/10.1001/jama.1940.02810460079037)\nPatel, M. K. & Orenstein, W. A. (2019). Classification of global measles cases in 2013\u201317 as due to policy or vaccination failure: a retrospective review of global surveillance data. The Lancet Global Health, 7(3), e313\u2013e320.\n[doi.org/10.1016/s2214-109x(18)30492-3](http://doi.org/10.1016/s2214-109x(18)30492-3)\nPaul Ehrlich-Institut. (2011, Juli). Bulletin zur Arzneimittelsicherheit. Abgerufen am 14. Juli 2022, von\n[https://www.pei.de/SharedDocs/Downloads/DE/newsroom/bulletin-arzneimittelsicherheit/2011/2-2011.pdf?__blob=publicationFile&v=2](https://www.pei.de/SharedDocs/Downloads/DE/newsroom/bulletin-arzneimittelsicherheit/2011/2-2011.pdf?__blob=publicationFile&v=2)\nPaul-Ehrlich-Institut. (2023, Juni 20). Masern-Impfstoffe. Arzneimittel \u2013 Impfstoffe.\n[https://www.pei.de/DE/arzneimittel/impfstoffe/masern/masern-node.html](https://www.pei.de/DE/arzneimittel/impfstoffe/masern/masern-node.html)\nPaunio, M., Heinonen, O. P., Virtanen, M., Leinikki, P., Patja, A., & Peltola, H. (2000). Measles history and atopic diseases: A population-based cross-sectional study. JAMA, 283(3), 343\u2013346.\n[https://doi.org/10.1001/jama.283.3.343](https://doi.org/10.1001/jama.283.3.343)\nPerry, R. T. & Halsey, N. A. (2004). The Clinical Significance of Measles: A Review. The Journal of Infectious Diseases, 189(Supplement_1), S4\u2013S16.\n[https://doi.org/10.1086/377712](https://doi.org/10.1086/377712)\nPlotkin S. A. (2010). Correlates of protection induced by vaccination. Clinical and vaccine immunology : CVI, 17(7), 1055\u20131065.\n[https://doi.org/10.1128/CVI.00131-10](https://doi.org/10.1128/CVI.00131-10)\nPoethko-M\u00fcller, C. & Mankertz, A. (2011). Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS). Vaccine, 29(45), 7949\u20137959.\n[https://doi.org/10.1016/j.vaccine.2011.08.081](https://doi.org/10.1016/j.vaccine.2011.08.081)\nRobert Koch-Institut. (2001, 20. Juli). Epidemiologisches Bulletin Nr. 29. Abgerufen am 14. Juli 2022, von\n[https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2001/Ausgabenlinks/29_01.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2001/Ausgabenlinks/29_01.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2010, 3. September). Ratgeber f\u00fcr \u00c4rzte - Masern. Abgerufen am 14. Juli 2022, von\n[https://web.archive.org/web/20120423141137/http://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Masern.html](https://web.archive.org/web/20120423141137/http://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Masern.html)\nRobert Koch-Institut. (2012). Kontraindikationen zur Durchf\u00fchrung von Impfungen: H\u00e4ufig gestellte Fragen und Antworten. Abgerufen von:\n[https://www.rki.de/SharedDocs/FAQ/Impfen/AllgFr_Kontraindi/faq_impfen_Kontraindi_ges.html](https://www.rki.de/SharedDocs/FAQ/Impfen/AllgFr_Kontraindi/faq_impfen_Kontraindi_ges.html)\nRobert Koch-Institut. (2013, 1. M\u00e4rz). Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten f\u00fcr 2012. Abgerufen am 14. Juli 2022, von\n[https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2012.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2012.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2015a, Februar 9). Paramyxoviren. EM-Aufnahmen.\n[https://www.rki.de/DE/Content/Infekt/NRZ/EM/Aufnahmen/EM-Tab_Paramyxoviren.html](https://www.rki.de/DE/Content/Infekt/NRZ/EM/Aufnahmen/EM-Tab_Paramyxoviren.html)\nRobert Koch-Institut. (2015b, 9. M\u00e4rz). Epidemiologisches Bulletin Nr. 10. Abgerufen am 22. Juni 2015, von\n[https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2015/Ausgaben/10_15.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2015/Ausgaben/10_15.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2016). Ist eine Impfung mit MMR-Impfstoff bei H\u00fchnereiwei\u00dfallergie m\u00f6glich? Abgerufen von:\n[https://www.rki.de/SharedDocs/FAQ/Impfen/MMR/FAQ10.html](https://www.rki.de/SharedDocs/FAQ/Impfen/MMR/FAQ10.html)\nRobert Koch-Institut. (2017, 1. M\u00e4rz). Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten f\u00fcr 2016. Abgerufen am 14. Juli 2022, von\n[https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2016.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2016.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2021a, 23. Juli). RKI-Ratgeber - Masern. Abgerufen am 14. Juli 2022, von\n[https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Masern.html](https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Masern.html)\nRobert Koch-Institut. (2021b, November 4). Antworten auf h\u00e4ufig gestellte Fragen zur Schutzimpfung gegen Masern. Zielgruppe, Impfempfehlung, Impfschema.\n[https://www.rki.de/SharedDocs/FAQ/Impfen/MMR/FAQ_Uebersicht_MSG.html](https://www.rki.de/SharedDocs/FAQ/Impfen/MMR/FAQ_Uebersicht_MSG.html)\nRobert Koch-Institut. (2022). Epidemiologisches Bulletin. Aktuelle Daten und Informationen zu Infektionskrankheiten und Public Health, 34/2022.\n[https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/34_22.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/34_22.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2023a, M\u00e4rz 1). Epidemiologische Situation der Masern und R\u00f6teln in Deutschland in 2022. Eliminationsprogramme.\n[https://www.rki.de/DE/Content/Infekt/Impfen/Praevention/elimination_04_01.html](https://www.rki.de/DE/Content/Infekt/Impfen/Praevention/elimination_04_01.html)\nRobert Koch-Institut. (2023b, M\u00e4rz 14). Elimination der Masern und R\u00f6teln in Deutschland. Eliminationsprogramme.\n[https://www.rki.de/DE/Content/Infekt/Impfen/Praevention/elimination_04.html#](https://www.rki.de/DE/Content/Infekt/Impfen/Praevention/elimination_04.html#)\nRoost, H.-P., Gassner, M., Grize, L., W\u00fcthrich, B., Sennhauser, F. H., Varonier, H. S., Zimmermann, H., & Braun-Fahrl\u00e4nder, C. (2004). Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 15(5), 401\u2013407.\n[https://doi.org/10.1111/j.1399-3038.2004.00192.x](https://doi.org/10.1111/j.1399-3038.2004.00192.x)\nRota, J. S., Wang, Z. D., Rota, P. A., & Bellini, W. J. (1994). Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus research, 31(3), 317\u2013330.\n[https://doi.org/10.1016/0168-1702(94)90025-6](https://doi.org/10.1016/0168-1702(94)90025-6)\nRosen, J. B., Rota, J. S., Hickman, C. J., Sowers, S. B., Mercader, S., Rota, P. A., . . . Zimmerman, C. M. (2014). Outbreak of Measles Among Persons With Prior Evidence of Immunity, New York City, 2011. Clinical Infectious Diseases, 58(9), 1205\u20131210.\n[https://doi.org/10.1093/cid/ciu105](https://doi.org/10.1093/cid/ciu105)\nRowhani-Rahbar, A., Fireman, B., Lewis, E., Nordin, J., Naleway, A., Jacobsen, S. J., . . . Klein, N. P. (2013). Effect of Age on the Risk of Fever and Seizures Following Immunization With Measles-Containing Vaccines in Children. JAMA Pediatrics, 167(12), 1111.\n[https://doi.org/10.1001/jamapediatrics.2013.2745](https://doi.org/10.1001/jamapediatrics.2013.2745)\nRus, M., & Groselj, U. (2021). Ethics of Vaccination in Childhood-A Framework Based on the Four Principles of Biomedical Ethics. Vaccines, 9(2), 113.\n[https://doi.org/10.3390/vaccines9020113](https://doi.org/10.3390/vaccines9020113)\nSalzburg Global Seminar (2011). Salzburg statement on shared decision making. BMJ (Clinical research ed.), 342, d1745.\n[https://doi.org/10.1136/bmj.d1745](https://doi.org/10.1136/bmj.d1745)\nSantibanez, S., Niewiesk, S., Heider, A., Schneider-Schaulies, J., Berbers, G. A. M., Zimmermann, A., . . Hengel, H. (2005). Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? Journal of General Virology, 86(2), 365\u2013374.\n[doi.org/10.1099/vir.0.80467-0](http://doi.org/10.1099/vir.0.80467-0)\nSchaad, U. B. (1997). P\u00e4diatrische Infektiologie (2. Aufl.). M\u00fcnchen, Deutschland: Mediengruppe Oberfranken.\nSch\u00f6nberger, K., Ludwig, M. S., Wildner, M. & Weissbrich, B. (2013). Epidemiology of Subacute Sclerosing Panencephalitis (SSPE) in Germany from 2003 to 2009: A Risk Estimation. PLoS ONE, 8(7), e68909.\n[https://doi.org/10.1371/journal.pone.0068909](https://doi.org/10.1371/journal.pone.0068909)\nSilfverdal, S., Ehlin, A. & Montgomery, S. (2009). Breast-feeding and a subsequent diagnosis of measles. Acta Paediatrica, 98(4), 715\u2013719.\n[https://doi.org/10.1111/j.1651-2227.2008.01180.x](https://doi.org/10.1111/j.1651-2227.2008.01180.x)\nSood, S. B., Suthar, K., Martin, K. & Mather, K. (2017). Vaccine-associated measles in an immunocompetent child. Clinical Case Reports, 5(11), 1765\u20131767.\n[https://doi.org/10.1002/ccr3.1174](https://doi.org/10.1002/ccr3.1174)\nSundell, N., Dotevall, L., Sansone, M., Andersson, M., Lindh, M., Wahlberg, T., . . . Andersson, L. M. (2019). Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections. Eurosurveillance, 24(17), pii=1900114.\n[doi.org/10.2807/1560-7917.es.2019.24.17.1900114](http://doi.org/10.2807/1560-7917.es.2019.24.17.1900114)\nTaylor, L. E., Swerdfeger, A. L. & Eslick, G. D. (2014). Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies. Vaccine, 32(29), 3623\u20133629.\n[https://doi.org/10.1016/j.vaccine.2014.04.085](https://doi.org/10.1016/j.vaccine.2014.04.085)\nTesting Treatments interactive. (2013, 30. Juni). Wie geht es weiter? Abgerufen am 9. August 2022, von\n[https://de.testingtreatments.org/tt-main-text/12-wodurch-zeichnet-sich-eine-bessere-gesundheitsversorgung-aus/wie-geht-es-weiter/](https://de.testingtreatments.org/tt-main-text/12-wodurch-zeichnet-sich-eine-bessere-gesundheitsversorgung-aus/wie-geht-es-weiter/)\nUzicanin, A. & Zimmerman, L. (2011). Field Effectiveness of Live Attenuated Measles-Containing Vaccines: A Review of Published Literature. The Journal of Infectious Diseases, 204(suppl_1), S133\u2013S149.\n[https://doi.org/10.1093/infdis/jir102](https://doi.org/10.1093/infdis/jir102)\nWeigl, J. A. I., Puppe, W., Belke, O., Neus\u00fc\u00df, J., Bagci, F. & Schmitt, H. J. (2005). The Descriptive Epidemiology of Severe Lower Respiratory Tract Infections in Children in Kiel, Germany. Klinische P\u00e4diatrie, 217(5), 259\u2013267.\n[https://doi.org/10.1055/s-2004-820352](https://doi.org/10.1055/s-2004-820352)\nWilliamson, L. & Glaab, H. (2018). Addressing vaccine hesitancy requires an ethically consistent health strategy. BMC Medical Ethics, 19(1).\n[doi.org/10.1186/s12910-018-0322-1](https://doi.org/10.1186/s12910-018-0322-1)\nWissenschaftlicher Dienst des Deutschen Bundestags. 2016a. Verfassungsrechtliche Zul\u00e4ssigkeit einer Impfpflicht. WD 3 \u2013 3000 \u2013 019/16. 27.01.2016.\nWissenschaftlicher Dienst des Deutschen Bundestags. 2016b. Verfassungsm\u00e4\u00dfigkeit einer gesetzlichen Impfpflicht f\u00fcr Kinder. WD 3 \u2013 3000 \u2013 056/16. 03.03.2016\nWorld Health Organization. (2017). Weekly epidemiological record. WHO, 92, 205\u2013228. Abgerufen von\n[https://apps.who.int/iris/bitstream/handle/10665/255149/WER9217.pdf;jsessionid=DD14E0EA00D588E86C0EA5E8BA451C90?sequence=1](https://apps.who.int/iris/bitstream/handle/10665/255149/WER9217.pdf;jsessionid=DD14E0EA00D588E86C0EA5E8BA451C90?sequence=1)\nWorld Health Organization. (2021, 13. Juli). Measles, 1st dose (MCV1) Immunization coverage estimates by country. Abgerufen am 14. Juli 2022, von\n[http://apps.who.int/gho/data/node.main.A826](http://apps.who.int/gho/data/node.main.A826)\nWorld Health Organization. (2019). WHO UNICEF estimates of DTP3 coverage. Abgerufen von\n[https://web.archive.org/web/20190831183659/http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html](https://web.archive.org/web/20190831183659/http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html)\nZhang, Z., Chen, M., Wang, Y., Li, J., Li, X. & Lu, L. (2019). Seroepidemiology of measles in Beijing, China: a cross-sectional study. Human Vaccines & Immunotherapeutics, 15(9), 2112\u20132116.\n[doi.org/10.1080/21645515.2019.1581527](http://doi.org/10.1080/21645515.2019.1581527)\nZipprich, J., Winter, K., Hacker, J., Xia, D., Watt, J., Harriman, K., & Centers for Disease Control and Prevention (CDC) (2015). Measles outbreak--California, December 2014-February 2015. MMWR. Morbidity and mortality weekly report, 64(6), 153\u2013154. Abgerufen am 14. Juli 2022, von\n[https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a5.htm](https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a5.htm)", "language": null, "image": null, "pagetype": "article", "links": ["/", "/", "https://easyverein.com/public/AeIIE2019/", "https://forum.individuelle-impfentscheidung.de", "/impfungen/masern.html", "/", "/aktuelles.html", "/aktuelles/covid-19-impfpflicht.html", "/aktuelles/covid-19-impfung.html", "/aktuelles/covid-19-bei-kindern-und-jugendlichen.html", "/aktuelles/covid-19-impfpflicht-verfassungsbeschwerden.html", "/masern-impfpflicht-verfassungsbeschwerden.html", "/aktuelles/masern-impfpflicht.html", "/standpunkte.html", "/standpunkte/publikationen.html", "/standpunkte/faqs.html", "/standpunkte/podcasts.html", "/standpunkte/videos.html", "/standpunkte/twitter.html", "/newsletter/standard-titel.html", "/aktionen.html", "/aktionen/lauterdnaimstoff.html", "/aktionen/ifsgehtsogarnicht.html", "/standpunkt/profisgegenimpfpflicht.html", "/impfenohnepflicht.html", "/briefaktion.html", "/aktuelles/die-corona-impfpflicht-ist-das-falsche-instrument-1.html", "/aktionen/keine-impfpflicht-fuer-beschaeftigte-im-medizinischen-und-sozialen-bereich.html", "/2ggehtgarnicht-1.html", "/aktuelles/nichtmeinaerztetag.html", "/aktuelles/deutschland-braucht-keine-impfpflicht.html", "/impfungen.html", "/impfungen/covid-19.html", "/impfungen/diphtherie.html", "/impfungen/fsme.html", "/impfungen/guertelrose.html", "/impfungen/hpv.html", "/impfungen/influenza.html", "/impfungen/masern.html", "/impfungen/meningokokken.html", "/impfungen/mumps.html", "/impfungen/polio.html", "/impfungen/roeteln.html", "/impfungen/rsv.html", "/impfungen/tetanus.html", "/impfungen/windpocken.html", "/impfempfehlungen.html", "/wer-wir-sind/arztsuche.html", "/impfempfehlungen/alternative-impfstrategien.html", "/impfempfehlungen/leitbild.html", "/impfempfehlungen/off-label-use.html", "/wer-wir-sind.html", "/wer-wir-sind/vorstand.html", "/wer-wir-sind/mitarbeiterinnen.html", "/wer-wir-sind/leitbild.html", "/wer-wir-sind/satzung.html", "/wer-wir-sind/transparenz.html", "/wer-wir-sind/gruendung.html", "/wer-wir-sind/wie-wir-arbeiten.html", "/wer-wir-sind/mitglied-werden.html", "/presse.html", "/presse/pressebilder.html", "/newsletter.html", "/newsletter/archiv.html", "/mitglied-werden.html", "/spenden.html", "https://twitter.com/individ_impfen", "https://www.linkedin.com/company/individuelle-impfentscheidung", "https://www.instagram.com/individuelle_impfentscheidung/", "https://www.youtube.com/channel/UCCppnAfYzQaf2ruYrvqH5rA/featured", "https://odysee.com/@individuelle_impfentscheidung:3", "https://open.spotify.com/show/7jgmUbf87g4Ha0whVGaIAp?si=53cbfd723be44076", "/", "/impfungen.html", "/impfungen/masern.html", "/fileadmin/Fachbeitr%C3%A4ge/Masern/AEFI-One_Pager-Masern.pdf", "https://impf-info.de/", "/wer-wir-sind/wie-wir-arbeiten.html", "/standpunkte/podcasts.html", "/glossar.html#c303", "/glossar.html#c67", "https://individuelle-impfentscheidung.de/fileadmin/Fachbeitr\u00e4ge/Masern/EM_Masernvirus.jpg", "/glossar.html#c147", "/glossar.html#c6", "/glossar.html#c75", "/glossar.html#c84", "/glossar.html#c68", "/glossar.html#c132", "/glossar.html#c217", "/glossar.html#c70", "/glossar.html#c71", "/glossar.html#c256", "/glossar.html#c72", "/glossar.html#c276", "/glossar.html#c45", "/glossar.html#c69", "https://www.impf-info.de/die-impfungen/masern/113-masern-die-erkrankung.html", "/glossar.html#c175", "/glossar.html#c8", "/glossar.html#c145", "/glossar.html#c95", "/glossar.html#c146", "/glossar.html#c176", "/glossar.html#c43", "/glossar.html#c187", "/glossar.html#c186", "/glossar.html#c244", "/glossar.html#c282", "/glossar.html#c170", "/glossar.html#c167", "/glossar.html#c318", "/glossar.html#c189", "/glossar.html#c81", "/glossar.html#c109", "/glossar.html#c193", "/glossar.html#c100", "/glossar.html#c195", "/glossar.html#c201", "/glossar.html#c171", "/glossar.html#c309", "/glossar.html#c169", "/glossar.html#c190", "/glossar.html#c320", "/glossar.html#c192", "/glossar.html#c177", "/glossar.html#c101", "/glossar.html#c319", "/glossar.html#c211", "/glossar.html#c317", "/glossar.html#c133", "/glossar.html#c225", "/glossar.html#c284", "/impfungen/tetanus.html", "/glossar.html#c23", "/glossar.html#c143", "#c610", "https://www.kiggs-studie.de/deutsch/home.html", "/glossar.html#c241", "#c602", "/glossar.html#c110", "https://individuelle-impfentscheidung.de/aktuelles/videos.html", "https://impf-info.de/images/Med/Masern/Masern-Impfviren-Stammbaum.png", "/glossar.html#c46", "/glossar.html#c21", "http://impf-info.de/neben-wirkungen/wirkungen/250-titerbestimmungen-nach-impfungen-%C3%BCber-sinn-und-unsinn.html", "http://impf-info.de/neben-wirkungen/wirkungen/250-titerbestimmungen-nach-impfungen-%C3%BCber-sinn-und-unsinn.html", "/glossar.html#c47", "/impfungen.html", "#c603", "https://individuelle-impfentscheidung.de/aktuelles/detail/eilantrag-einzelimpfstoff-aus-der-schweiz", "#c608", "#c600", "https://impf-info.de/die-impfungen/masern/275-masernimpfung-einmal,-zweimal,-dreimal.html", "/glossar.html#c198", "https://impf-info.de/images/Med/Masern/Masern%20in%20D%20erstes%20LJ%202001-18.png", "https://impf-info.de/images/Med/Masern/Masern%20in%20D%20erstes%20LJ%202001-18.png", "https://impf-info.de/die-impfungen/masern/275-masernimpfung-einmal,-zweimal,-dreimal.html", "https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=8&SelectedCountryIdByDisease=-1", "/glossar.html#c111", "/impfungen/meningokokken.html", "/glossar.html#c243", "/glossar.html#c77", "https://impf-info.de/die-impfungen/masern/115-masern-die-impfung.html", "https://www.impf-info.de/die-impfentscheidung/die-diskussion-\u00fcber-die-impfpflicht/267-die-impfpflicht-wirksamkeit.html", "https://www.impf-info.de/die-impfungen/masern/115-masern-die-impfung.html", "https://www.impf-info.de/die-impfentscheidung/die-impfempfehlungen/181-impfempfehlungen-in-europa.html", "https://www.impf-info.de/die-impfungen/masern/249-masern-trotz-impfung-die-untersch%C3%A4tzte-gefahr.html", "https://www.impf-info.de/die-impfungen/masern/115-masern-die-impfung.html", "/glossar.html#c262", "/glossar.html#c144", "/glossar.html#c137", "/glossar.html#c76", "#c608", "https://www.impf-info.de/neben-wirkungen/immunsystem/254-impfen-sch%C3%BCtzt-wovor-eigentlich-genau.html", "https://www.impf-info.de/neben-wirkungen/wirkungen/205-herdenimmunit%C3%A4t.html", "/glossar.html#c94", "https://www.impf-info.de/neben-wirkungen/wirkungen/250-titerbestimmungen-nach-impfungen-%C3%BCber-sinn-und-unsinn.html", "https://www.impf-info.de/die-impfungen/diphtherie/226-die-r%C3%BCckkehr-der-diphtherie-ein-paar-alternative-fakten-wirklich-wahr-period.html", "https://www.impf-info.de/die-impfungen/hib/105-hib-die-erkrankungen.html", "https://www.impf-info.de/neben-wirkungen/wirkungen/218-die-ausrottung-von-krankheiten-das-beispiel-pocken.html", "https://www.impf-info.de/neben-wirkungen/wirkungen/219-die-ausrottung-von-krankheiten-das-beispiel-masern.html", "https://www.impf-info.de/die-impfentscheidung/impfaufklaerung/217-verfassungsrechtler-stiko-empfehlungen-verfassungswidrig-l%C3%BCckenhaft-nicht-sachgerecht.html", "https://www.eingeimpft-film.de", "#c608", "https://www.masern.express/", "https://www.apotheke-adhoc.de/nachrichten/detail/apothekenpraxis/kuendigung-trotz-boenigs-impfunfaehigkeitsbescheinigung/", "https://www.medstra-online.de/76864.htm#Beitrag3", "#", "#", "https://www.rki.de/DE/Content/Service/Publikationen/Fachwoerterbuch_Infektionsschutz.html", "https://www.ardmediathek.de/mdr/player/Y3JpZDovL21kci5kZS9iZWl0cmFnL2Ntcy85ZGQyMGEzYy04YTBiLTQ0YmItOTk4My0zOTA2YmYyMmE0YTQ/masern-impfpflicht-wird-umgangen", "/glossar.html#c140", "/glossar.html#c291", "/glossar.html#c10", "/glossar.html#c19", "/glossar.html#c103", "/glossar.html#c136", "https://individuelle-impfentscheidung.de/fileadmin/PDF/Masernschutzgesetz_FAQ_Kitas_und_Schulen_Stand_26.05.2023.pdf", "https://individuelle-impfentscheidung.de/aktuelles/detail/nachtraegliche-veroeffentlichung-der-stellungnahme-an-das-bundesverfassungsgericht-zum-masernschutzgesetz.html", "https://individuelle-impfentscheidung.de/aktuelles/detail/masernschutzgesetz-ablauf-der-uebergangsfrist-zum-31072022-rechtliche-hinweise.html", "https://individuelle-impfentscheidung.de/aktuelles/detail/masernimpfpflicht-entscheidung-ueber-verfassungsmaessigkeit-im-schulbereich-und-in-medizinischen-einrichtungen-steht-weiter-aus.html", "/fileadmin/PDF/Masernschutzgesetz_FAQ_Kitas_und_Schulen_Stand_26.05.2023.pdf", "#", "#", "http://doi.org/10.1093/infdis/154.5.858", "https://portal.dimdi.de/amispb/doc/pei/Web/2603289-spcde-20091001.pdf", "http://doi.org/10.1093/cid/cix974", "https://doi.org/10.1620/tjem.230.111", "https://web.archive.org/web/20180711000720/https://www.apotheken-umschau.de/Infektion/Braucht-Deutschland-eine-Impfpflicht-548597.html", "https://www.arznei-telegramm.de/html/2013_10/1310085_01.html", "http://www.asset-scienceinsociety.eu/reports/page1.html", "http://doi.org/10.2807/1560-7917.es.2018.23.28.1800328", "http://doi.org/10.15585/mmwr.mm6742a4", "https://doi.org/10.1093/infdis/jir097", "http://doi.org/10.1093/oxfordjournals.aje.a112170", "https://doi.org/10.2807/1560-7917.es.2016.21.27.30277", "http://www.kvs-sachsen.de/fileadmin/data/kvs/img/Mitglieder/KVS-Mitteilungen/2017-02/2017-02_schutzimpfungen.pdf", "http://doi.org/10.3201/eid0401.980105", "https://doi.org/10.1542/peds.104.5.1123", "https://doi.org/10.1111/j.1399-3038.2007.00684.x", "/glossar.html#c138", "https://doi.org/10.1093/eurpub/ckv154", "/glossar.html#c62", "http://doi.org/10.1093/infdis/jiz508", "https://doi.org/10.1086/520449", "http://doi.org/10.2807/1560-7917.es.2019.24.17.1800529", "/glossar.html#c233", "https://doi.org/10.1093/infdis/jiac039", "https://doi.org/10.1093/ije/dym207", "http://doi.org/10.1093/cid/cix510", "http://doi.org/10.1097/00006454-199501000-00003", "https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html", "http://doi.org/10.1016/j.vaccine.2012.05.019", "http://doi.org/10.2807/1560-7917.es.2018.23.37.1800485", "http://pubmed.ncbi.nlm.nih.gov/4359359/", "http://doi.org/10.1093/cid/ciy286", "/glossar.html#c107", "http://doi.org/10.1016/0264-410x(94)90049-3", "http://www.cnscbt.ro/index.php/informari-saptamanale/rujeola-1/682-situatia-deceselor-datorate-rujeolei-romania-2016-2017/file", "http://www.cnscbt.ro/index.php/informari-saptamanale/rujeola-1/690-situatia-rujeolei-in-romania-la-data-de-19-05-2017-1", "https://doi.org/10.1016/j.vaccine.2008.08.074", "http://doi.org/10.1086/314847", "https://doi.org/10.1093/cid/cis439", "https://doi.org/10.1111/bioe.12019", "https://doi.org/10.1542/peds.2012-3975", "/glossar.html#c64", "https://doi.org/10.1002/14651858.cd004407.pub3", "https://www.ethikrat.org/fileadmin/Publikationen/Stellungnahmen/deutsch/stellungnahme-impfen-als-pflicht.pdf", "https://www.deutschlandfunk.de/thomas-fischbach-vs-jan-leidel-braucht-deutschland-eine-100.html?dram:article_id=411412", "https://www.deutschlandfunk.de/debatte-ums-impfen-fuer-ein-fortschrittliches-land-haben-100.html", "https://doi.org/10.1002/14651858.CD004407.pub5", "https://doi.org/10.1093/infdis/jiw512", "https://atlas.ecdc.europa.eu/public/index.aspx", "https://www.ecdc.europa.eu/en/publications-data/measles-annual-epidemiological-report-2022", "https://doi.org/10.1128/cvi.00084-13", "http://doi.org/10.1001/jama.1990.03440180073035", "https://web.archive.org/web/20120503041132/http://www.nice.org.uk/nicemedia/live/12247/45529/45529.pdf", "https://doi.org/10.1016/s0140-6736(96)04429-7", "https://www.ema.europa.eu/en/documents/referral/priorix-article-30-referral-annex-iii_de.pdf", "http://doi.org/10.2105/ajph.70.11.1166", "https://doi.org/10.1016/s0140-6736(95)90471-9", "http://doi.org/10.1093/femspd/ftw089", "https://www.aerzteblatt.de/archiv/65460/Aerztliche-Gesundheitszeugnisse-Vorsicht-ist-geboten", "http://doi.org/10.1093/infdis/jiv555", "https://doi.org/10.1001/jamapediatrics.2019.4357", "https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.584.5748&rep=rep1&type=pdf", "https://doi.org/10.2807/1560-7917.es.2017.22.17.30524", "http://http://", "https://doi.org/10.2807/1560-7917.es2015.20.3.21012", "https://www.impfkritik.de/upload/pdf/fachinfo/Priorix-Glaxo-2003-01.pdf", "https://www.forum-impfen.de/images/Fachinfo/Priorix_Tetra_12_19.pdf", "https://doi.org/10.1016/j.vaccine.2016.03.092", "https://doi.org/10.1007/s11673-018-9841-1", "https://doi.org/10.1097/00006454-199306000-00002", "https://doi.org/10.1586/erv.12.134", "http://pubmed.ncbi.nlm.nih.gov/9829639/", "https://doi.org/10.1093/infdis/173.6.1320", "https://doi.org/10.1111/ped.12064", "http://doi.org/10.1007/s10654-019-00569-4", "https://doi.org/10.1016/s0264-410x(03)00271-8", "http://http://", "https://doi.org/10.1007/s004310050658", "https://www.wiwo.de/technologie/forschung/masern-epidemie-eine-masern-impfpflicht-wird-nichts-bringen/11418274.html", "https://doi.org/10.1155/2014/205617", "https://doi.org/10.1136/bmj.c1626", "https://doi.org/10.1056/nejmoa1407417", "https://www.welt.de/gesundheit/article13679613/Masern-auf-dem-Weg-zur-Erwachsenen-Krankheit.html", "https://doi.org/10.1016/j.vaccine.2008.06.028", "https://doi.org/10.2807/ese.14.50.19442-en", "https://doi.org/10.1016/j.vaccine.2013.08.044", "https://doi.org/10.1093/infdis/jit804", "http://doi.org/10.2105/ajph.79.4.475", "https://doi.org/10.1007/s00103-013-1799-x", "/glossar.html#c153", "https://www.ardmediathek.de/mdr/player/Y3JpZDovL21kci5kZS9iZWl0cmFnL2Ntcy85ZGQyMGEzYy04YTBiLTQ0YmItOTk4My0zOTA2YmYyMmE0YTQ/masern-impfpflicht-wird-umgangen", "https://www.forum-impfen.de/images/Fachinfo/M_M_RVAXPRO_08_20.pdf", "https://www.fachinfo.de/pdf/021469", "https://doi.org/10.3238/arztebl.2011.0191", "https://webarchive.nationalarchives.gov.uk/ukgwa/20141205150130/http://www.mhra.gov.uk/home/groups/pl-p/documents/websiteresources/con019510.pdf", "https://doi.org/10.1136/adc.2003.038489", "https://doi.org/10.1186/s12916-015-0508-z", "https://doi.org/10.1016/s0140-6736(89)91274-9", "http://doi.org/10.2807/1560-7917.es.2018.23.24.1800239", "https://doi.org/10.1016/s0022-3476(94)70318-3", "https://doi.org/10.1016/s0264-410x(01)00495-9", "https://doi.org/10.1016/B978-0-12-369408-9.00030-5", "http://doi.org/10.1016/s0264-410x(03)00449-3", "http://doi.org/10.1093/oxfordjournals.aje.a009951", "https://doi.org/10.1016/s0264-410x(00)00455-2", "https://doi.org/10.2807/1560-7917.es2013.18.49.20649", "https://web.archive.org/web/20190122224140/http://www.rki.de/DE/Content/Kommissionen/NAVKO/Berichte/Bericht_2013_de.pdf?__blob=publicationFile", "https://doi.org/10.1186/s12889-022-14075-y", "https://doi.org/10.1080/00015550310014997", "https://doi.org/10.1016/C2013-0-18914-3", "http://doi.org/10.1001/jama.1940.02810460079037", "http://doi.org/10.1016/s2214-109x(18)30492-3", "https://www.pei.de/SharedDocs/Downloads/DE/newsroom/bulletin-arzneimittelsicherheit/2011/2-2011.pdf?__blob=publicationFile&v=2", "https://www.pei.de/DE/arzneimittel/impfstoffe/masern/masern-node.html", "https://doi.org/10.1001/jama.283.3.343", "https://doi.org/10.1086/377712", "https://doi.org/10.1128/CVI.00131-10", "https://doi.org/10.1016/j.vaccine.2011.08.081", "https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2001/Ausgabenlinks/29_01.pdf?__blob=publicationFile", "https://web.archive.org/web/20120423141137/http://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Masern.html", "https://www.rki.de/SharedDocs/FAQ/Impfen/AllgFr_Kontraindi/faq_impfen_Kontraindi_ges.html", "https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2012.pdf?__blob=publicationFile", "https://www.rki.de/DE/Content/Infekt/NRZ/EM/Aufnahmen/EM-Tab_Paramyxoviren.html", "https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2015/Ausgaben/10_15.pdf?__blob=publicationFile", "https://www.rki.de/SharedDocs/FAQ/Impfen/MMR/FAQ10.html", "https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2016.pdf?__blob=publicationFile", "https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Masern.html", "https://www.rki.de/SharedDocs/FAQ/Impfen/MMR/FAQ_Uebersicht_MSG.html", "https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/34_22.pdf?__blob=publicationFile", "https://www.rki.de/DE/Content/Infekt/Impfen/Praevention/elimination_04_01.html", "https://www.rki.de/DE/Content/Infekt/Impfen/Praevention/elimination_04.html#", "https://doi.org/10.1111/j.1399-3038.2004.00192.x", "https://doi.org/10.1016/0168-1702(94)90025-6", "https://doi.org/10.1093/cid/ciu105", "https://doi.org/10.1001/jamapediatrics.2013.2745", "https://doi.org/10.3390/vaccines9020113", "https://doi.org/10.1136/bmj.d1745", "http://doi.org/10.1099/vir.0.80467-0", "https://doi.org/10.1371/journal.pone.0068909", "https://doi.org/10.1111/j.1651-2227.2008.01180.x", "https://doi.org/10.1002/ccr3.1174", "http://doi.org/10.2807/1560-7917.es.2019.24.17.1900114", "https://doi.org/10.1016/j.vaccine.2014.04.085", "https://de.testingtreatments.org/tt-main-text/12-wodurch-zeichnet-sich-eine-bessere-gesundheitsversorgung-aus/wie-geht-es-weiter/", "https://doi.org/10.1093/infdis/jir102", "https://doi.org/10.1055/s-2004-820352", "https://doi.org/10.1186/s12910-018-0322-1", "https://apps.who.int/iris/bitstream/handle/10665/255149/WER9217.pdf;jsessionid=DD14E0EA00D588E86C0EA5E8BA451C90?sequence=1", "http://apps.who.int/gho/data/node.main.A826", "https://web.archive.org/web/20190831183659/http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragedtp3.html", "http://doi.org/10.1080/21645515.2019.1581527", "https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6406a5.htm", "/", "/aktuelles.html", "/standpunkte.html", "/aktionen.html", "/impfungen.html", "/impfempfehlungen.html", "/wer-wir-sind.html", "/presse.html", "/newsletter.html", "/mitglied-werden.html", "/spenden.html", "/standpunkte.html", "/standpunkte/publikationen.html", "/standpunkte/faqs.html", "/standpunkte/podcasts.html", "/standpunkte/videos.html", "/standpunkte/twitter.html", "/newsletter/standard-titel.html", "/impfungen.html", "/impfungen/covid-19.html", "/impfungen/diphtherie.html", "/impfungen/fsme.html", "/impfungen/guertelrose.html", "/impfungen/hpv.html", "/impfungen/influenza.html", "/impfungen/masern.html", "/impfungen/meningokokken.html", "/impfungen/mumps.html", "/impfungen/polio.html", "/impfungen/roeteln.html", "/impfungen/rsv.html", "/impfungen/tetanus.html", "/impfungen/windpocken.html", "/wer-wir-sind.html", "/wer-wir-sind/vorstand.html", "/wer-wir-sind/mitarbeiterinnen.html", "/wer-wir-sind/leitbild.html", "/wer-wir-sind/satzung.html", "/wer-wir-sind/transparenz.html", "/wer-wir-sind/gruendung.html", "/wer-wir-sind/wie-wir-arbeiten.html", "/datenschutz.html", "/impressum.html", "", "https://twitter.com/individ_impfen", "https://www.linkedin.com/company/individuelle-impfentscheidung", "https://www.instagram.com/individuelle_impfentscheidung/", "https://www.youtube.com/channel/UCCppnAfYzQaf2ruYrvqH5rA/featured", "https://odysee.com/@individuelle_impfentscheidung:3", "https://open.spotify.com/show/7jgmUbf87g4Ha0whVGaIAp?si=53cbfd723be44076", "/datenschutz.html", null, "/datenschutz.html", null, null, null, "https://forum.individuelle-impfentscheidung.de", "/impfungen/masern.html", "https://easyverein.com/public/AeIIE2019/applicationform/", "/impfungen/masern.html", "https://easyverein.com/public/AeIIE2019", "/impfungen/masern.html", "https://easyverein.com/public/AeIIE2019/applicationform/", "/impfungen/masern.html"]}